_PRIVATE_LIMITED.webp)
Cinnabaris Spagyrics (Herbals) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -24.27%
(FY 2022)
- Profit -25.78%
(FY 2022)
- Ebitda 26.17%
(FY 2022)
- Net Worth 4.68%
(FY 2022)
- Total Assets 3.15%
(FY 2022)
About Cinnabaris Spagyrics (Herbals)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanhita Munier, Kirit Munier, Pierre Munier, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231PN2000PTC015147
- Company No.
015147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cinnabaris Spagyrics (Herbals) Private Limited offer?
Cinnabaris Spagyrics (Herbals) Private Limited offers a wide range of products and services, including Metal & Metal Made Products, Metal Ingots, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Cinnabaris Spagyrics (Herbals)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanhita Munier  | Director | 25-Jul-2000 | Current |
| Kirit Munier | Director | 01-Mar-2010 | Current |
| Pierre Munier | Director | 25-Jul-2000 | Current |
| Arun Munier | Director | 24-Jan-2022 | Current |
Financial Performance of Cinnabaris Spagyrics (Herbals).
Cinnabaris Spagyrics (Herbals) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.27% decrease. The company also saw a substantial fall in profitability, with a 25.78% decrease in profit. The company's net worth moved up by a moderate rise of 4.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cinnabaris Spagyrics (Herbals)?
In 2019, Cinnabaris Spagyrics (Herbals) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cinnabaris Spagyrics (Herbals)?
Unlock and access historical data on people associated with Cinnabaris Spagyrics (Herbals), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cinnabaris Spagyrics (Herbals), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cinnabaris Spagyrics (Herbals)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
